Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea

Helen Fowles (Hull, United Kingdom), Helen Fowles, Alyn Morice, Yvette Hayman, Kayleigh Arnell

Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Session: Novel treatments for cough, asthma, COPD and bronchiectasis
Session type: Thematic Poster Session
Number: 3964
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Helen Fowles (Hull, United Kingdom), Helen Fowles, Alyn Morice, Yvette Hayman, Kayleigh Arnell. Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea. Eur Respir J 2015; 46: Suppl. 59, 3964

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of Levodropropizine: 2 metanalysis in pediatric and adult population
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014


Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016

The effect of Octreotide in patients with refractory Chronic Cough
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014


Antibiotic or symptomatic therapy in URTI-related pediatric acute cough?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Efficacy and response predictors of inhaled corticosteroid treatment on chronic cough
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014


LATE-BREAKING ABSTRACT: Safety and efficacy of inhaled mannitol over 12 months in high-risk patients with non-CF bronchiectasis
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Use of inhaled corticoids and presence of eosinophilia in patients with COPD: TRACE Cohort
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Abediterol: Efficacy, safety and tolerability of the novel LABA in patients with persistent asthma
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014


Safety of tiotropium in renally impaired patients
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Pharmacokinetics of tiotropium in asthma patients from three paediatric clinical trials
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Inflammation in COPD patients before and after roflumilast treatment
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014

Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Safety of once-daily tiotropium and olodaterol fixed-dose combination via the respimat in chronic obstructive pulmonary disease in two 1-year studies
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014